Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 12/8/2009
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||0384U / 0||UN / IM|
Administered by: Other Purchased by: Other
Symptoms: Dizziness, Nausea, Vomiting, Drug exposure during pregnancy, Ultrasound abdomen, Laboratory test
Life Threatening? No
Permanent Disability? No
ER or Doctor Visit? Yes
Other Medications: Folic acid; Vitamins (unspecified)
Current Illness: Pregnancy NOS (LMP = 2/26/2007); Asthma; Type II diabetes mellitus
Diagnostic Lab Data: Abdominal ultrasound results not reported. Diagnostic laboratory results not reported.
CDC 'Split Type': WAES0705USA04349
Write-up:Information has been received through a pregnancy registry from two licensed practical nurses concerning a 21 year old female with asthma and type II diabetes mellitus who on 23-MAR-2007 was vaccinated with the first dose of Gardasil (lot #655618/0186U). On 18-APR-2007 the patient had a positive pregnancy test. The patient was vaccinated with the second dose on 23-MAY-2007 Gardasil (lot #657617/0384U). (It was also reported that this was the patients first dose). Concomitant therapy included prenatal vitamins (unspecified) and folic acid. Subsequently, on 23-MAY-2007 within one hour of the vaccine, the patient experienced dizziness, nausea and vomiting. The patient was prescribed promethazine hydrochloride (PHENERGAN) and symptoms are resolving. Patient had prenatal blood work and abdominal ultrasound, results not reported. The patient is pregnant with twins. The last menstrual period was 26-FEB-2007 with estimated delivery date is 03-DEC-2007. (The last menstrual period was also reported as 03-MAR-2007). Additional information has been requested.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166